Culturally Aware Support for Hormone Therapy in Breast Cancer Survivors

Recruiting in Palo Alto (17 mi)

+10 other locations

Overseen byJamie M Jacobs, PhD

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Massachusetts General Hospital

No Placebo Group

Trial Summary

What is the purpose of this trial?The purpose of this study is to examine the feasibility and acceptability of a brief, nurse-led intervention to support breast cancer survivors who have delayed initiation of hormonal therapy or who have concerns about starting hormonal therapy.

Eligibility Criteria

This trial is for female breast cancer survivors, aged 21 or older, with early-stage hormone receptor-positive breast cancer. They must be recommended to start AET but have either delayed it or are hesitant to begin treatment. Participants should be able to communicate in English or Spanish and have a stable physical condition (ECOG ≤ 2). Women from minority communities are especially encouraged to join.

Inclusion Criteria

I am female.

At least 10 participants should be from a racial or ethnic minority group based on their own reporting.

I am recommended to start or have hesitations about starting hormone therapy for my cancer.

+4 more

Exclusion Criteria

I do not have cognitive issues that prevent me from joining the study.

You are currently receiving treatment for another type of cancer.

You are currently in another clinical trial that involves AET.

+1 more

Participant Groups

The study is testing a nurse-led intervention designed to help women who are reluctant or have postponed starting their prescribed hormonal therapy after surviving breast cancer. The focus is on the cultural awareness aspect of the intervention's effectiveness and its overall acceptability among patients.

1Treatment groups

Experimental Treatment

Group I: Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation InterventionExperimental Treatment1 Intervention

Participants will have two (2), 60 minute, individual sessions with a nurse practitioner via videoconferencing (in person or via telephone) and complete three (3) questionnaires at the time of enrollment, 1-month post-baseline, and 3-months post-baseline.